First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru

Descripción del Articulo

Introduction: Currently, infections by the SARS-CoV-2 virus exceed 600 million cases in the world. Objective: Isolation and characterization of the SARS-CoV-2 virus causing COVID-19 at the beginning of the pandemic in Peru. Materials and methods: Twenty nasal and pharyngeal swab samples were isolate...

Descripción completa

Detalles Bibliográficos
Autores: García, María P., Palomino-Rodríguez, Miryam, Hernández, Marcos, Rios-Monteza, Pamela, Huaringa-Nuñez, Maribel, Guevara, Carolina, Otárola, Jannet, Padilla-Rojas, C., Mestanza, Orson, Gavilan, Ronnie Gustavo, Merino-Sarmiento , Nancy, De Lucio-Burga , Gabriel, Cabezas, César
Formato: artículo
Fecha de Publicación:2023
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
inglés
OAI Identifier:oai:ojs.csi.unmsm:article/24134
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134
Nivel de acceso:acceso abierto
Materia:Coronavirus Infections
Betacoronavirus
Vero Cells
Virulence
Infecciones por Coronavirus
Células Vero
Virulencia
id REVUNMSM_3254f463b912a721dd22e5f0b0cdb973
oai_identifier_str oai:ojs.csi.unmsm:article/24134
network_acronym_str REVUNMSM
network_name_str Revistas - Universidad Nacional Mayor de San Marcos
repository_id_str
dc.title.none.fl_str_mv First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
Primer aislamiento y caracterización de la cepa prototipo del virus SARS-CoV-2 a inicios de la pandemia de la COVID-19 en el Perú
title First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
spellingShingle First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
García, María P.
Coronavirus Infections
Betacoronavirus
Vero Cells
Virulence
Infecciones por Coronavirus
Betacoronavirus
Células Vero
Virulencia
title_short First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
title_full First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
title_fullStr First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
title_full_unstemmed First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
title_sort First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in Peru
dc.creator.none.fl_str_mv García, María P.
Palomino-Rodríguez, Miryam
Hernández, Marcos
Rios-Monteza, Pamela
Huaringa-Nuñez, Maribel
Guevara, Carolina
Otárola, Jannet
Padilla-Rojas, C.
Mestanza, Orson
Gavilan, Ronnie Gustavo
Merino-Sarmiento , Nancy
De Lucio-Burga , Gabriel
Cabezas, César
García, María P.
Palomino-Rodríguez, Miryam
Hernández, Marcos
Rios-Monteza, Pamela
Huaringa-Nuñez, Maribel
Guevara, Carolina
Otárola, Jannet
Padilla-Rojas, C.
Mestanza, Orson
Gavilan, Ronnie Gustavo
Merino-Sarmiento , Nancy
De Lucio-Burga , Gabriel
Cabezas, César
author García, María P.
author_facet García, María P.
Palomino-Rodríguez, Miryam
Hernández, Marcos
Rios-Monteza, Pamela
Huaringa-Nuñez, Maribel
Guevara, Carolina
Otárola, Jannet
Padilla-Rojas, C.
Mestanza, Orson
Gavilan, Ronnie Gustavo
Merino-Sarmiento , Nancy
De Lucio-Burga , Gabriel
Cabezas, César
Guevara, Carolina
Mestanza, Orson
Gavilan, Ronnie Gustavo
author_role author
author2 Palomino-Rodríguez, Miryam
Hernández, Marcos
Rios-Monteza, Pamela
Huaringa-Nuñez, Maribel
Guevara, Carolina
Otárola, Jannet
Padilla-Rojas, C.
Mestanza, Orson
Gavilan, Ronnie Gustavo
Merino-Sarmiento , Nancy
De Lucio-Burga , Gabriel
Cabezas, César
Guevara, Carolina
Mestanza, Orson
Gavilan, Ronnie Gustavo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Coronavirus Infections
Betacoronavirus
Vero Cells
Virulence
Infecciones por Coronavirus
Betacoronavirus
Células Vero
Virulencia
topic Coronavirus Infections
Betacoronavirus
Vero Cells
Virulence
Infecciones por Coronavirus
Betacoronavirus
Células Vero
Virulencia
description Introduction: Currently, infections by the SARS-CoV-2 virus exceed 600 million cases in the world. Objective: Isolation and characterization of the SARS-CoV-2 virus causing COVID-19 at the beginning of the pandemic in Peru. Materials and methods: Twenty nasal and pharyngeal swab samples were isolated SARS-CoV-2 using two cell lines, Vero ATCC CCL-81 and Vero E-6; virus identification was performed by RT-PCR and the onset of cytopathic effect (CPE) was evaluated by indirect immunofluorescence and subsequent identification by genomic sequencing. One of the most widely circulating isolates was selected and named the prototype strain (PE/B.1.1/28549/2020). Then 10 successive passages were performed in Vero ATCC CCL-81 cells to assess mutation dynamics. Results: Results detected 11 virus isolates by cytopathic effect, and subsequently confirmed by RT-PCR and indirect immunofluorescence. Of these, six were sequenced and identified as the lineages B.1, B.1.1, B.1.1.1, and B.1.205 according to the Pango lineage nomenclature. The prototype strain corresponded to lineage B.1.1. The analysis of the strains from the successive passages showed mutations mainly at in the spike (S) protein of the virus without variation in the identity of the lineage. Conclusions: Four lineages were isolated in the Vero ATCC CCL-81 cell line. Subcultures in the same cell line show mutations in the spike protein indicating greater adaptability to the host cell and variation in pathogenicity in vitro, a behavior that allows it to have more survival success.
publishDate 2023
dc.date.none.fl_str_mv 2023-02-28
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134
10.15381/anales.v84i1.24134
url https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134
identifier_str_mv 10.15381/anales.v84i1.24134
dc.language.none.fl_str_mv spa
eng
language spa
eng
dc.relation.none.fl_str_mv https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134/19317
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134/19318
dc.rights.none.fl_str_mv Derechos de autor 2023 Anales de la Facultad de Medicina
http://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2023 Anales de la Facultad de Medicina
http://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana
dc.source.none.fl_str_mv Anales de la Facultad de Medicina; Vol. 84 No. 1 (2023); 55-62
Anales de la Facultad de Medicina; Vol. 84 Núm. 1 (2023); 55-62
1609-9419
1025-5583
reponame:Revistas - Universidad Nacional Mayor de San Marcos
instname:Universidad Nacional Mayor de San Marcos
instacron:UNMSM
instname_str Universidad Nacional Mayor de San Marcos
instacron_str UNMSM
institution UNMSM
reponame_str Revistas - Universidad Nacional Mayor de San Marcos
collection Revistas - Universidad Nacional Mayor de San Marcos
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1795238259449659392
spelling First isolation and characterization of the prototype strain of SARS-CoV-2 at the beginning of the COVID-19 pandemic in PeruPrimer aislamiento y caracterización de la cepa prototipo del virus SARS-CoV-2 a inicios de la pandemia de la COVID-19 en el PerúGarcía, María P. Palomino-Rodríguez, MiryamHernández, Marcos Rios-Monteza, PamelaHuaringa-Nuñez, MaribelGuevara, CarolinaOtárola, JannetPadilla-Rojas, C.Mestanza, OrsonGavilan, Ronnie GustavoMerino-Sarmiento , NancyDe Lucio-Burga , GabrielCabezas, CésarGarcía, María P. Palomino-Rodríguez, MiryamHernández, Marcos Rios-Monteza, PamelaHuaringa-Nuñez, Maribel Guevara, CarolinaOtárola, JannetPadilla-Rojas, C. Mestanza, Orson Gavilan, Ronnie GustavoMerino-Sarmiento , NancyDe Lucio-Burga , GabrielCabezas, CésarCoronavirus InfectionsBetacoronavirusVero CellsVirulenceInfecciones por CoronavirusBetacoronavirusCélulas VeroVirulenciaIntroduction: Currently, infections by the SARS-CoV-2 virus exceed 600 million cases in the world. Objective: Isolation and characterization of the SARS-CoV-2 virus causing COVID-19 at the beginning of the pandemic in Peru. Materials and methods: Twenty nasal and pharyngeal swab samples were isolated SARS-CoV-2 using two cell lines, Vero ATCC CCL-81 and Vero E-6; virus identification was performed by RT-PCR and the onset of cytopathic effect (CPE) was evaluated by indirect immunofluorescence and subsequent identification by genomic sequencing. One of the most widely circulating isolates was selected and named the prototype strain (PE/B.1.1/28549/2020). Then 10 successive passages were performed in Vero ATCC CCL-81 cells to assess mutation dynamics. Results: Results detected 11 virus isolates by cytopathic effect, and subsequently confirmed by RT-PCR and indirect immunofluorescence. Of these, six were sequenced and identified as the lineages B.1, B.1.1, B.1.1.1, and B.1.205 according to the Pango lineage nomenclature. The prototype strain corresponded to lineage B.1.1. The analysis of the strains from the successive passages showed mutations mainly at in the spike (S) protein of the virus without variation in the identity of the lineage. Conclusions: Four lineages were isolated in the Vero ATCC CCL-81 cell line. Subcultures in the same cell line show mutations in the spike protein indicating greater adaptability to the host cell and variation in pathogenicity in vitro, a behavior that allows it to have more survival success.Introducción: Actualmente los contagios por el virus del SARS-CoV-2 supera los 600 millones de casos en el mundo. Objetivo: Aislar y caracterizar el virus SARS-CoV-2 causante de la COVID-19 a inicios de la pandemia en el Perú. Materiales y métodos: Se realizó el aislamiento viral a partir de 20 muestras de hisopado nasal y faríngeo positivas a SARS-CoV-2 por RT-PCR. El aislamiento se realizó en las líneas celulares Vero ATCC CCL-81 y Vero E6, evaluando el efecto citopático, la presencia del virus por RT-PCR, inmunofluorescencia indirecta (IFI) y posterior identificación por secuenciación genómica. Posteriormente, uno de los aislamientos de mayor circulación fue seleccionado y denominado cepa prototipo (PE/B.1.1/28549/2020), realizándose 10 pasajes sucesivos en células Vero ATCC CCL-81 para evaluar la dinámica de mutaciones. Resultados: Se observaron 11 aislamientos de virus por efecto citopático confirmándose por RT-PCR e IFI, de los cuales 6 fueron secuenciados identificándose los linajes B.1, B.1.1, B.1.1.1 y B.1.205, según el comité Pango de los genomas. La cepa prototipo corresponde a la variante B.1.1 y el análisis de las secuencias de los pasajes sucesivos mostró mutaciones a nivel de la proteína de la espiga (S) del virus, sin variación en la identidad del linaje. Conclusiones: Se aislaron 4 linajes en la línea celular Vero ATCC CCL-81. Los subcultivos en la misma línea celular muestran mutaciones en la proteína de la espiga, lo que indica mayor adaptabilidad a la célula hospedera y variación de la patogenicidad in vitro, comportamiento que le permite tener más éxito de supervivencia.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2023-02-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/2413410.15381/anales.v84i1.24134Anales de la Facultad de Medicina; Vol. 84 No. 1 (2023); 55-62Anales de la Facultad de Medicina; Vol. 84 Núm. 1 (2023); 55-621609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspaenghttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134/19317https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/24134/19318Derechos de autor 2023 Anales de la Facultad de Medicinahttp://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/241342023-04-03T12:06:24Z
score 13.982926
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).